Anteris Technologies

Open enrollment across a mixed-phase pipeline

According to ClinicalTrials.gov-derived indexes, Anteris Technologies sits in the upper half of US sponsors by registered trial count (#4,885 of 15,742 sponsors by registered trial count).

2 total trials 1 currently recruiting upper half by trial count

Anteris Technologies: 2 sponsored US clinical trials, 1 recruiting.

Anteris Technologies sponsors 2 registered US clinical trials on ClinicalTrials.gov, 1 of them currently recruiting. The most-studied condition in this pipeline is Aortic Valve Calcification, with 1 trials.

Mid-pack sponsor footprint

Anteris Technologies is in the upper half of sponsors by trial count (#4,885 of 15,742 sponsors by registered trial count). Use the pipeline list and therapeutic areas to see what drives that mid-pack volume.

What is open in the Anteris Technologies pipeline

1 recruiting of 2 indexed (50% open).

Phase labels are sparse on this sponsor index, so phase mix is not charted here.

Top condition: Aortic Valve Calcification (1 trial), 3 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Anteris Technologies: open-pipeline peers nationwide

Peers matched on 2 registered trials and 50% open enrollment, not the therapeutic-area sidebar.

Anteris Technologies sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 1.522.533.544.5 0%20%40%60% Total trials Recruiting share Anteris Technologies1200 Pharma1ST Biotherapeutics3 Waves Wellness3EO Health3ive Labs60 Degrees Pharmaceuticals7 Hills PharmaAbcentra
Anteris Technologies sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Anteris Technologies sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 2 trials (± recruiting share)

Sponsors near 50% open enrollment (± trial volume)

What to do with this Anteris Technologies page

2 registered trials is a research-attention snapshot, not an endorsement of Anteris Technologies or any single study.

  • 1 of Anteris Technologies's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Aortic Valve Calcification is the condition Anteris Technologies studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Aortic Valve Calcification trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Anteris Technologies pipeline card: 2 registered trials from official public datasets.Report a data error.